SQID.F Stock Overview
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
SQI Diagnostics Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.015 |
52 Week High | CA$0.12 |
52 Week Low | CA$0.0093 |
Beta | 0.075 |
1 Month Change | 0% |
3 Month Change | 14.62% |
1 Year Change | -82.47% |
3 Year Change | -91.98% |
5 Year Change | -84.81% |
Change since IPO | -98.53% |
Recent News & Updates
Recent updates
Shareholder Returns
SQID.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | -0.2% | 1.3% |
1Y | -82.5% | 10.6% | 29.8% |
Return vs Industry: SQID.F underperformed the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: SQID.F underperformed the US Market which returned 15.2% over the past year.
Price Volatility
SQID.F volatility | |
---|---|
SQID.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SQID.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SQID.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Andrew Morris | https://www.sqidiagnostics.com |
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow.
SQI Diagnostics Inc. Fundamentals Summary
SQID.F fundamental statistics | |
---|---|
Market cap | US$4.48m |
Earnings (TTM) | -US$14.03m |
Revenue (TTM) | US$2.23m |
2.0x
P/S Ratio-0.3x
P/E RatioIs SQID.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SQID.F income statement (TTM) | |
---|---|
Revenue | CA$3.05m |
Cost of Revenue | CA$3.19m |
Gross Profit | -CA$140.00k |
Other Expenses | CA$19.00m |
Earnings | -CA$19.14m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.047 |
Gross Margin | -4.60% |
Net Profit Margin | -628.51% |
Debt/Equity Ratio | -103.3% |
How did SQID.F perform over the long term?
See historical performance and comparison